Page 73 - TD-3-3
P. 73

Tumor Discovery                                            Pyroptosis-related genes in breast cancer progression




             A                          B                             C












                         D                                E











                         F
                                                         G














            Figure 10. (A-C) Expression of prognostic genes in breast cancer (BC). In MDA-MB-231 cells and MDA-MB-468 cells, the expressions of APOBEC3D and
            APOBEC3F were much higher than in BT549 and MCF7. Notably, the same antibody was used for detecting both proteins APOBEC3D and APOBEC3F
            in western blotting. (D-G) In addition, the expressions of PXDNL and ARMH1 were significantly higher in BC cells.
            Notes: P-values: ns = not significant; *P < 0.05; **P < 0.01; ***P < 0.001.

            additional research is needed to address the remaining   Conflict of interest
            questions and confirm these findings.
                                                               The authors declare that the research was conducted in the
            5. Conclusion                                      absence of any commercial or financial relationships that
                                                               could be construed as a potential conflicts of interest.
            We identified four high-risk genes – FIBCD1, CACNA1H,
            HSPB8, and PXDNL – that are involved in BC pyroptosis.   Author contributions
            Notably,  the  expression  of  PXDNL  was significantly   Conceptualization:  Shanshan Wang, Dashuang Yang,
            elevated in BC cells in vitro, suggesting that PXDNL could   Jiaqian Mo
            serve as a new target for early diagnosis and prognosis in   Formal analysis: Moxian Chen
            BC.                                                Investigation: Shanshan Wang, Dashuang Yang, Jiaqian Mo

            Acknowledgments                                    Methodology: Shanshan Wang, Dashuang Yang, Jiaqian Mo
                                                               Writing-original draft: Shanshan Wang, Dashuang Yang,
            None.                                                 Jiaqian Mo
                                                               Writing-review & editing: Rongxin Zhang
            Funding
            This work was supported by the Administration of   Ethics approval and consent to participate
            Traditional Chinese Medicine of Guangdong Province   All BC clinical data were downloaded from the TCGA
            (No. 20221218).                                    database. The data provided by the database are ethically


            Volume 3 Issue 3 (2024)                         14                                doi: 10.36922/td.3469
   68   69   70   71   72   73   74   75   76   77   78